Stayce D. Harris, Director at BlackRock Capital Allocation Term Trust (BCAT), bought 60 shares at $16.04 ($962) on 2024-10-28, disclosed to the SEC on 2024-10-29.
Open-market purchase of $962 BCAT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| BGT | BUY | 2024-10-30 | $131 | — | Filing → |
| BHK | BUY | 2024-10-30 | $114 | — | Filing → |
| BBN | BUY | 2024-10-30 | $164 | — | Filing → |